Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro

Porcine reproductive and respiratory syndrome virus (PRRSV) infection has inflicted devastating impacts on the global swine industry, while current vaccines provide limited protection against this disease. Mogroside V (MV), a triterpenoid compound derived from Siraitia grosvenorii, exhibits diverse...

Full description

Saved in:
Bibliographic Details
Main Authors: Longhua Liang, Xiaohui Huang, Guoxi Qin, Xiaoyu Ma, Rijing He, Hongpeng Dai, Zhen Zhang, Xiaogan Yang, Xingwei Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1611600/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839642776147329024
author Longhua Liang
Longhua Liang
Xiaohui Huang
Xiaohui Huang
Guoxi Qin
Guoxi Qin
Xiaoyu Ma
Rijing He
Rijing He
Hongpeng Dai
Hongpeng Dai
Zhen Zhang
Zhen Zhang
Xiaogan Yang
Xiaogan Yang
Xingwei Liang
Xingwei Liang
author_facet Longhua Liang
Longhua Liang
Xiaohui Huang
Xiaohui Huang
Guoxi Qin
Guoxi Qin
Xiaoyu Ma
Rijing He
Rijing He
Hongpeng Dai
Hongpeng Dai
Zhen Zhang
Zhen Zhang
Xiaogan Yang
Xiaogan Yang
Xingwei Liang
Xingwei Liang
author_sort Longhua Liang
collection DOAJ
description Porcine reproductive and respiratory syndrome virus (PRRSV) infection has inflicted devastating impacts on the global swine industry, while current vaccines provide limited protection against this disease. Mogroside V (MV), a triterpenoid compound derived from Siraitia grosvenorii, exhibits diverse biological activities including antioxidant, anti-inflammatory, and anti-cancer properties, with the capacity to scavenge free radicals and mitigate oxidative stress. In this study, MV was administered to PRRSV-infected cells via three distinct treatment modalities. Our findings demonstrate that MV effectively blocks or suppresses infections caused by diverse PRRSV subtypes in porcine alveolar macrophages (PAMs) and Marc-145 cells. MV exhibited significant dose-dependent antiviral efficacy, with viral titers and mRNA expression inhibited by over 90% at a concentration of 400 μM. Comparative analysis further revealed substantial variations in antiviral efficacy among the different treatment protocols. Notably, PRRSV employs immune evasion mechanisms to suppress host innate immunity. MV not only directly inhibited PRRSV replication but also significantly upregulated the gene expression of immunomodulatory cytokines (IL-1, IL-2, IL-8, IL-18; P < 0.05), suggesting a dual mechanism of antiviral action. These findings underscore the antiviral bioactivity of MV and highlight its potential as a novel therapeutic candidate for PRRSV intervention.
format Article
id doaj-art-10399a6f757241bd9d836f8045cc76c2
institution Matheson Library
issn 1664-302X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-10399a6f757241bd9d836f8045cc76c22025-07-02T05:51:55ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-07-011610.3389/fmicb.2025.16116001611600Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitroLonghua Liang0Longhua Liang1Xiaohui Huang2Xiaohui Huang3Guoxi Qin4Guoxi Qin5Xiaoyu Ma6Rijing He7Rijing He8Hongpeng Dai9Hongpeng Dai10Zhen Zhang11Zhen Zhang12Xiaogan Yang13Xiaogan Yang14Xingwei Liang15Xingwei Liang16College of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Agricultural Reclamation Yongxin Livestock Group Jinguang Livestock Co., Ltd, Nanning, ChinaGuangxi Agricultural Reclamation Yongxin Livestock Group Jinguang Livestock Co., Ltd, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaCollege of Animal Science and Technology, Guangxi University, Nanning, ChinaGuangxi Key Laboratory of Animal Breeding & Disease Control and Prevention, Guangxi University, Nanning, ChinaPorcine reproductive and respiratory syndrome virus (PRRSV) infection has inflicted devastating impacts on the global swine industry, while current vaccines provide limited protection against this disease. Mogroside V (MV), a triterpenoid compound derived from Siraitia grosvenorii, exhibits diverse biological activities including antioxidant, anti-inflammatory, and anti-cancer properties, with the capacity to scavenge free radicals and mitigate oxidative stress. In this study, MV was administered to PRRSV-infected cells via three distinct treatment modalities. Our findings demonstrate that MV effectively blocks or suppresses infections caused by diverse PRRSV subtypes in porcine alveolar macrophages (PAMs) and Marc-145 cells. MV exhibited significant dose-dependent antiviral efficacy, with viral titers and mRNA expression inhibited by over 90% at a concentration of 400 μM. Comparative analysis further revealed substantial variations in antiviral efficacy among the different treatment protocols. Notably, PRRSV employs immune evasion mechanisms to suppress host innate immunity. MV not only directly inhibited PRRSV replication but also significantly upregulated the gene expression of immunomodulatory cytokines (IL-1, IL-2, IL-8, IL-18; P < 0.05), suggesting a dual mechanism of antiviral action. These findings underscore the antiviral bioactivity of MV and highlight its potential as a novel therapeutic candidate for PRRSV intervention.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1611600/fullPRRSVmogroside Vantiviral actionantioxidantcytokines
spellingShingle Longhua Liang
Longhua Liang
Xiaohui Huang
Xiaohui Huang
Guoxi Qin
Guoxi Qin
Xiaoyu Ma
Rijing He
Rijing He
Hongpeng Dai
Hongpeng Dai
Zhen Zhang
Zhen Zhang
Xiaogan Yang
Xiaogan Yang
Xingwei Liang
Xingwei Liang
Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro
Frontiers in Microbiology
PRRSV
mogroside V
antiviral action
antioxidant
cytokines
title Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro
title_full Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro
title_fullStr Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro
title_full_unstemmed Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro
title_short Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro
title_sort antiviral effects of mogroside v against porcine reproductive and respiratory syndrome virus in vitro
topic PRRSV
mogroside V
antiviral action
antioxidant
cytokines
url https://www.frontiersin.org/articles/10.3389/fmicb.2025.1611600/full
work_keys_str_mv AT longhualiang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT longhualiang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xiaohuihuang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xiaohuihuang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT guoxiqin antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT guoxiqin antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xiaoyuma antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT rijinghe antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT rijinghe antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT hongpengdai antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT hongpengdai antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT zhenzhang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT zhenzhang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xiaoganyang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xiaoganyang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xingweiliang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro
AT xingweiliang antiviraleffectsofmogrosidevagainstporcinereproductiveandrespiratorysyndromevirusinvitro